Europe Conjugate Vaccine Market (2018-2023)

Publisher Name :
Date: 06-Jun-2018
No. of pages: 90

Europe Conjugate Vaccine Market:

Conjugate vaccine is a type of vaccine that contains bacterial capsular polysaccharide, attached with a protein to enhance immunogenicity and protect against invasive diseases. Europe is a market with stable growth for conjugate vaccines. The conjugate vaccine market in Europe is expected to expand at a CAGR of 3.6% leading to a revenue of USD 8.94 Bn by 2023. By volume, it is anticipated to reach 504.46 Million units by 2023, expanding at a CAGR of 3.7%.

The U.K. was the first country to introduce MenB-4C into their National Infant Immunization Program (2015). In all EU/EEA countries, Hib vaccination has been part of the immunization programs, since 2010, and high coverage has been sustained.

Market Segmentation:

o Based on disease indication, the market is segmented into pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal and others.

o Based on end user, the market is segmented into pediatric and adult.

o Based on countries, the Europe market is divided into EU5 and Rest of EU.

Key growth factors:

The European market will not display any extraordinary growth but average figures. Key growth factors include increasing emphasis on and availability of funds for research and development. Moreover, advancements in medical science, awareness about the availability of a higher number of vaccines for diseases will drive the growth of this market. Increasing vaccination programs by government, their initiatives, and increase in research and development activities will result in the growth of this market.

Threats and key players:

o The Europe conjugate vaccine market is expected to grow at a steady pace. The scope for significant growth is limited. Vaccine shortages are a major problem which will hinder the growth of the market. The shortage of vaccines affecting some EU/EEA Member States had direct effects on the delivery of national vaccination programmes. Since 2015, nine EU/EEA member states had to adjust their immunization policies.

o Major conjugate vaccine providers operating in the market are GlaxoSmithKline, Pfizer Inc., Merck, Novartis, Sanofi Pasteur, etc.

What's covered in the report?

1. Overview of the Europe conjugate vaccine market

2. Market drivers and challenges in the Europe conjugate vaccine market

3. Market trends in the Europe conjugate vaccine market

4. Historical, current and forecasted market size data for Europe based on disease indication (pneumococcal, haemophilus influenza type b, diphtheria-tetanus-pertussis, meningococcal conjugate vaccines) - by revenue and by volume

5. Historical, current and forecasted market size data for Europe based on end user (pediatric and adult conjugate vaccines) - by revenue and by volume

6. Historical, current and forecasted market size data of conjugate vaccines based on countries (EU5, Rest of EU) - by revenue and by volume

7. Historical, current and forecasted market size data for country-wise segments - by revenue and by volume

8. Analysis of the competitive landscape and profiles of major companies operating in the European market

Why buy?

o Understand the demand for conjugate vaccines to determine the viability of the market

o Understand the country-specific market size and observations for each segment

o Develop strategies based on the drivers, trends and highlights for each of the segments

o Evaluate the value chain to determine the workflow and to get an idea of the current position where you are placed

o Recognize the key competitors of this market and respond accordingly

o Identify the initiatives and growth strategies taken up by the major companies and decide on the direction for further growth

o Define the competitive positioning by comparing the products and services with the key players in the market

Customizations available

With the given market data, Netscribes offers customizations according to specific needs. Write to us at [email protected].

Europe Conjugate Vaccine Market (2018-2023)

Table of Contents

Chapter 1: Executive summary
1.1 Market scope and segmentation
1.2 Key questions answered in this study
1.3 Executive summary - I
1.4 Executive summary - II

Chapter 2: Market overview
2.1. Market definitions
2.2. Europe market overview - by revenue
- Europe historical (2015-2017) market revenue (USD Bn)
- Europe forecasted (2018-2023) market revenue (USD Bn)
- Country-wise market (2018-2023) revenue (USD Bn)
2.3. Europe market overview - by volume
- Europe historical (2015-2017) market volume (Million units)
- Europe forecasted (2018-2023) market volume (Million units)
- Country-wise (2018-2023) market volume (Million units)
2.4. Europe market drivers and challenges
2.4.1. Europe market drivers
2.4.2. Europe market challenges
2.5. Europe market trends
2.6. Value chain
2.7.1. Country-specific market overview - EU5
- Observation
- Key competitors
2.7.1(A) Country-specific market overview - EU5 - by revenue and by volume
- EU5 historical (2015-2017) market revenue (USD Bn)
- EU5 forecasted (2018-2023) market revenue (USD Bn)
- EU5 historical (2015-2017) market volume (Million units)
- EU5 forecasted (2018-2023) market volume (Million units)
2.7.2. Country-specific market overview - Rest of EU
- Observation
- Key competitors
2.7.2(A) Country-specific market overview - Rest of EU by revenue and by volume
- Rest of EU historical (2015-2017) market revenue (USD Bn)
- Rest of EU forecasted (2018-2023) market revenue (USD Bn)
- Rest of EU historical (2015-2017) market volume (Million units)
- Rest of EU forecasted (2018-2023) market volume (Million units)

Chapter 3: Europe major segment overview - by disease indication
3.1. Disease indication: Pneumococcal, Hib - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): Pneumococcal - Europe (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Hib - Europe (USD Bn, Million units)
3.2. Disease indication: DTP, Meningococcal - by revenue, by volume, CAGR
- Overview - by disease indication
- Market share (2015, 2018 & 2023): DTP - Europe (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Meningococcal - Europe (USD Bn, Million units)

Chapter 4: Europe major segment overview - by end user
4.1. End-user: Pediatric, Adult - by revenue, by volume, CAGR
- Overview - by end-user
- Market share (2015, 2018 & 2023): Paediatric - Europe (USD Bn, Million units)
- Market share (2015, 2018 & 2023): Adult - Europe (USD Bn, Million units)

Chapter 5: EU5 - by disease indication
5.1. EU5: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.2. EU5: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.3. EU5: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
5.4. EU5: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 6: EU5 - by end user
6.1. EU5: end-user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 7: Rest of EU - by disease indication
7.1. Rest of EU: disease indication - Pneumococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.2. Rest of EU: disease indication - Haemophilus Influenza type b conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.3. Rest of EU: disease indication - Diphtheria-Tetanus-Pertussis conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways
7.4. Rest of EU: disease indication - Meningococcal conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Highlights, Key takeaways

Chapter 8: Rest of EU - by end user
8.1. Rest of EU: end-user - Pediatric & Adult conjugate vaccine market size (USD Bn, Million units) (2015, 2018, 2023), Key takeaways

Chapter 9: Competitive landscape
9.1. Company market share
- Top 5 companies
9.2. Company overview - GlaxoSmithKline
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
9.2(A) Executive profile - GlaxoSmithKline
9.3. Company overview - Pfizer Inc.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
9.3(A) Executive profile - Pfizer Inc.
9.4. Company overview - Merck & Co.
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
9.4(A) Executive profile - Merck & Co.
9.5. Company overview - Novartis
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
9.5(A) Executive profile - Novartis
9.6. Company overview - Sanofi Pasteur
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
9.6(A) Executive profile - Sanofi Pasteur
9.7. Company overview - CSL Limited
- Company snapshot
- Product offerings
- Growth strategies
- Initiatives
- Geographical presence
9.7(A) Executive profile - CSL Limited

Appendix
- List of tables
- Assumptions
- Conclusion
- Research methodology
- About Netscribes Inc.

Disclaimer: The Table of Contents (ToC) provided above contains the targeted coverage. The coverage is subject to change as we progress with the research

  • Global Antioxidant Vitamins Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100
    The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......
  • Global Clavulanate Potassium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......
  • Global Amoxicillin Sodium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84
    The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......
  • Global Melatonin Supplements Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106
    The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......
  • Global Sleeping Pills (Prescription Drugs) Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93
    The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......
  • Global Sleeping Pills Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......
  • Global Zinc Oral Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......
  • Global Zinc Drops Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......
  • Global Anti-Infectives Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs